AmbioPharm's Financial Acquisition

AmbioPharm raised a round of funding on November 20, 2014. Investors include MVM Life Science Partners.

Ambio Holdings, dba AmbioPharm (APi), is a global peptide active pharmaceutical ingredient (API) contract development and manufacturing organization (CDMO). It has established a custom peptide supply …

Articles about AmbioPharm's Financial Acquisition: